SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Pherin Pharmaceuticals, Inc. Reports Favorable Clinical, Regulatory, and Intellectual Property Actions on Novel Intranasal Medication for Acute Treatment of Social Anxiety Disorder and Issuance of Patents in the U.S.A. and Other Major Countries